Skip to content
healthcare.dev

AMJEVITA

NDC 55513-413, adalimumab-atto, injection, from Amgen, Inc.

Product NDC
55513-413
Status
Listed
Labeler
Amgen, Inc
Dosage form
INJECTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761024
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55513-413 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ADALIMUMAB10 mg/.2mL

Pharmacologic classes

Antibodies, Monoclonal [CS]; Tumor Necrosis Factor Blocker [EPC]; Tumor Necrosis Factor Receptor Blocking Activity [MoA]

Package NDCNDC-11Package
55513-413-01555130413011 SYRINGE in 1 CARTON (55513-413-01) / .2 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9c44bd5b-4464-40a4-8933-8680950f00f2

Use it

Look up 55513-413 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55513-413 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55513-413. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.